HomeNewsBusinessReal EstateCOVID-19 impact | Commercial rentals may fall by 5-10%
Trending Topics

COVID-19 impact | Commercial rentals may fall by 5-10%

Work from home may gain strength, but likely to account only 10-15 percent of the workforce.

June 19, 2020 / 19:46 IST
Story continues below Advertisement

The outbreak of coronavirus disease will have a short-term impact on India's office market, with demand likely to fall by 45 per cent and rentals softening by 5-10 percent, said Anshul Jain, Managing Director- India and South East Asia, Cushman & Wakefield.

The net leasing or absorption of office space may fall to 25 million sq ft this year as against 45 million sq ft during 2019, he projected.

Story continues below Advertisement

Jain, however, was bullish on the medium-to-long term growth prospects of the office market in India, which he said would continue to be an attractive destination for outsourcing of various kinds of jobs. The de-densification of office space would largely compensate for any fall in demand due to adoption of Work From Home (WFH) policy by corporates, he added.

Jain was speaking at a webinar organised by Workplace Trends India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show